Brand profile · Biotechnology

Optalert

Optalert works in Biotechnology, out of Cremorne, VIC. Ownership is privately held; it publishes at optalert.com. It holds one address on record, all in Australia. The record counts 35 people. Tagged neurology, pharmaceutical and oem. Two Australian registrations (ABN) are candidate matches. The record links four similar brands, most of them in Software Development.

Profile live Privately Held Founded 2004 2 registry matches ABN 1 office country
Registry match · ABR

Key facts

Counted staff
35
self-reported 11–50 band
Founded
2004
22 years
Registry matches
2
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entities

1 brand → 2 possible registrationsThese are name matches on ABR. 2 registrations share this brand's name; which one you contract with is a question for the register.
  • OPTALERT HOLDINGS PTY LIMITED

    ABN20100362883

    VICMedium confidenceMatched on exact nameABR

  • OPTALERT AUSTRALIA PTY LTD

    ABN79121747591

    VICMedium confidenceMatched on exact nameABR

Legal entities

Optalert: 2 registry entitiesOptalert is linked to 2 registry entities: OPTALERT HOLDINGS PTY LIMITED (ABN 20100362883, candidate); OPTALERT AUSTRALIA PTY LTD (ABN 79121747591, candidate).OptalertOPTALERT HOLDINGS PTYLIMITEDABN 20100362883Candidate · Medium confidenceOPTALERT AUSTRALIA PTYLTDABN 79121747591Candidate · Medium confidence
Show as table · Optalert: 2 registry entities
Optalert: 2 registry entities
OPTALERT HOLDINGS PTY LIMITEDABN 20100362883
OPTALERT AUSTRALIA PTY LTDABN 79121747591
Confirmed matches0 of 2

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Optalert developed the world’s leading algorithm to quantify the deterioration in cognitive brain function due to drowsiness and created the Johns Drowsiness Scale (JDS) which remains the only scientifically proven, objective measurement of drowsiness.

The JDS is used worldwide in research for accurately quantifying drowsiness levels, and in Optalert’s early-warning drowsiness detection systems to protect thousands of lives and valuable company assets across multiple industries. Our clients include BHP Billiton, Vale and NASA. Our research partners include the Harvard Medical School, Monash University, and the University of Queensland.

Optalert is a Medical Technology company pioneering the use of Blepharometry (the measurement of blinks) to measure drowsiness. Optalert discovered a key biomarker for drowsiness, the connection between brain function and eyelid movement.

Optalert is now turning its extensive expertise in Blepharometry and Artificial Intelligence to identify the biomarkers for other degradations to neurological brain function in conditions such as Epilepsy (due to onset of seizures), ADHD, Parkinson’s, Alzheimer’s, TBI, concussion and motor neuron disease.

Specialties

All 41 specialties
  • Fatigue Management
  • Alertness Monitoring
  • Fatigue Risk Profiling
  • Drowsiness Detection
  • Wearable Technology
  • Early warning drowsiness detection
  • Data reporting
  • Risk reduction from Fatigue related accidents
  • Licensing
  • Pharmaceutical
  • Epworth Sleepiness Scale
  • Johns Drowsiness Scale
  • JDS
  • ESS
  • Medical Trials
  • machine learning
  • neurology
  • Sleep
  • Epilepsy
  • Shiftwork
  • TBI
  • Traumatic Brain Injury
  • Wakefulness
  • Automotive
  • Inattention
  • OEM
  • Distraction
  • Artificial Intelegence
  • CNS
  • Central Nervous System
  • Sleepiness
  • Clinical Trials
  • Neurotoxicity
  • Murray Johns
  • Drowsy Driving
  • Microsleeps
  • Fatigue
  • Driver Monitoring Systems
  • NCAP
  • EURONCAP
  • Biomarkers

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryAU

All codes: AU

Addresses

  • AULevel 6, 3 Newton St; Cremorne, VIC 3121Primary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entities operate under Optalert?

Two Victoria entities on the ABR. OPTALERT HOLDINGS PTY LIMITED (ABN 20 100 362 883) and OPTALERT AUSTRALIA PTY LTD (ABN 79 121 747 591). Both medium confidence.

How many people work at Optalert?

The record holds 35 counted staff profiles at January 2026, inside the self-reported 11–50 band.

Where does Optalert have offices?

One address on record, Australia only. Primary: Level 6, 3 Newton St, Cremorne, VIC 3121.

Has Optalert raised funding?

None linked to this brand.

What does Optalert list as its specialties?

41 tags on the brand's own list, among them neurology, pharmaceutical and oem.

Which companies are listed alongside Optalert?

Four peer profiles on record: Vennu and Nimo Industries.

What is Optalert's website?